NCT00982904View on ClinicalTrials.gov

Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the Fexinidazole

PHASE1CompletedINTERVENTIONAL

Enrollment

108

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

September 30, 2010

Study Completion Date

October 31, 2010

Conditions

Human African Trypanosomiasis

Interventions

DRUG

Fexinidazole/Placebo

Trial Locations (1)

75015

SGS Aster, Paris

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Sanofi

INDUSTRY

lead

Drugs for Neglected Diseases

OTHER